These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22027314)

  • 41. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals.
    Pfützner A; Bailey T; Campos C; Kahn D; Ambers E; Niemeyer M; Guerrero G; Klonoff D; Nayberg I
    Curr Med Res Opin; 2013 May; 29(5):475-81. PubMed ID: 23402225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose accuracy of a durable insulin pen with memory function, before and after simulated lifetime use and under stress conditions.
    Xue L; Mikkelsen KH
    Expert Opin Drug Deliv; 2013 Mar; 10(3):301-6. PubMed ID: 23330725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of dosing accuracy: visually impaired and sighted people using insulin pens.
    Williams AS; Schnarrenberger PA
    J Diabetes Sci Technol; 2010 May; 4(3):514-21. PubMed ID: 20513315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injection force and dose accuracy of FlexTouch for the delivery of a new basal insulin.
    Götzche D; Rasmussen BØ; Pedersen MT; Sparre T; Bucher D; Niemeyer M
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1613-9. PubMed ID: 24256325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose accuracy testing of the humalog/ humulin insulin pen device.
    Roe MJ; Ignaut D; Miyakawa T; Hultman C
    Diabetes Technol Ther; 2001; 3(4):623-9. PubMed ID: 11911175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy and precision of the NovoPen 3 insulin delivery device after mechanical and temperature stresses.
    Santiago OM; Khutoryansky NM; Bilbo CM; Lawton SA; Kristensen CM
    Endocr Pract; 2002; 8(5):351-5. PubMed ID: 15251837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis and perspective: A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Bailey TS
    J Diabetes Sci Technol; 2011 Sep; 5(5):1222-3. PubMed ID: 22027322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM; Borgman SK
    Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.
    Wang T; Conrad KA; van Brunt K; Rees TM
    J Diabetes Sci Technol; 2016 Jul; 10(4):923-31. PubMed ID: 26920640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.
    Graff MR; McClanahan MA
    Clin Ther; 1998; 20(3):486-96. PubMed ID: 9663364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NovoPen Echo(®) insulin delivery device.
    Hyllested-Winge J; Sparre T; Pedersen LK
    Med Devices (Auckl); 2016; 9():11-8. PubMed ID: 26793007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin pens.
    Gebel E
    Diabetes Forecast; 2012 Jan; 65(1):56-7. PubMed ID: 22283102
    [No Abstract]   [Full Text] [Related]  

  • 53. Dose accuracy and injection force of disposable pens delivering pramlintide for the treatment of diabetes.
    Merritt D; Schreiner B; Harris S; DeYoung MB; Strobel S; Lauinger J
    J Diabetes Sci Technol; 2010 Nov; 4(6):1438-46. PubMed ID: 21129339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4.
    Donsmark M; Herold L; Kristensen CM
    Diabetes Technol Ther; 2009 Sep; 11(9):581-5. PubMed ID: 19764837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An analysis of the HumaPen Luxura HD pen: what is the role of 0.5-unit insulin dosing?
    Magnotti MA; Rayfield EJ
    J Diabetes Sci Technol; 2010 Mar; 4(2):357-8. PubMed ID: 20307397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis: linking laboratory data to human factors and inclusion of persons with disabilities in diabetes technology research.
    Williams AS
    J Diabetes Sci Technol; 2011 Sep; 5(5):1191-4. PubMed ID: 22027316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.
    Friedrichs A
    Diabetes Technol Ther; 2009 Sep; 11(9):609-13. PubMed ID: 19764841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump.
    Keith K; Nicholson D; Rogers D
    Clin Pediatr (Phila); 2004; 43(1):69-74. PubMed ID: 14968895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.